Healthcare
Synoste raises €2.8m in seed round
High-Tech Gründerfonds (HTGF), Finnvera, Lifeline Ventures, Tekes and a consortium of business angels have backed medical devices company Synoste with €2.8m.
VC-backed uniQure to float
Dutch gene therapy company uniQure, backed by several venture capital firms, has filed a confidential F-1 form with the US Securities and Exchange Commission (SEC) for a potential IPO.
BPE sells Domilens to Odewald’s Polytech
BPE Unternehmensbeteiligungen has sold medical devices manufacturer Domilens to fellow private equity house Odewald & Compagnie’s Polytech Gruppe, a medical equipment supplier.
DFJ Esprit’s Oxford Immunotec to float
Oxford Immunotec Global, a UK-based medical diagnostics company, has filed with the US Security and Exchange Commission (SEC) for an IPO on the Nasdaq that would value the company at up to $245.4m.
HTGF et al. invest in m2p-labs
High-Tech-Gründerfonds (HTGF) and Fidura Private Equity Fonds have backed m2p-labs, a German manufacturer of measuring solutions for the biotech sector.
Italian-German start-up Wise raises €1m
High-Tech Gründerfonds (HTGF), Atlante Seed, b-to-v Partners and Agite have backed medical devices company Wiringless Implantable Stretchable Electronics (Wise) in a €1m seed round.
Vallis joins Inter-Risco in 32 Senses
Vallis Capital Partners has provided expansion capital to Portuguese dental business 32 Senses.
HTGF et al. back HiperScan with €450,000
High-Tech Gründerfonds (HTGF), HCS Beteiligungsgesellschaft and the Technologiegründerfonds Sachsen have backed near-infrared spectroscopy (NIR) developer HiperScan with €450,000.
Sovereign’s Eden acquires Essential Futures
UK buy-and-build specialist Sovereign Capital has backed the acquisition of Essential Futures by portfolio company Eden.
PMV backs arGEN-X
PMV has invested €5m in arGEN-X, a Dutch and Belgian biotechnology firm, in an extension of the company’s 2011 series-B round, which now totals €32.5m.
Biocartis secures €30m from PMV et al.
Swiss molecular diagnostics firm Biocartis has raised €30m in its series-E round from a group of investors including PMV, Debiopharm Diagnostics and Johnson & Johnson Development Corporation (JJDC).
Ippon leads £10m investment in Midatech
Nanomedicines manufacturer Midatech has raised £10m in a funding round led by Geneva-based private equity house Ippon Capital.
Sofinnova, Forbion lead €20m round for Hookipa
A consortium of investors led by Sofinnova Partners and Forbion Capital Partners has invested €20m in a series-B funding round for Austria-based Hookipa Biotech.
EdRip closes fourth life sciences fund on €192m
Edmond de Rothschild Investment Partners (EdRip) has held the final close of its fourth life sciences fund, BioDiscovery 4, on €192m.
General Atlantic to sell Amedes for up to $1bn
General Atlantic has put German laboratory services provider Amedes up for sale, according to reports.
Capricorn, Vesalius lead round for Trod
Capricorn Venture Partners and Vesalius Biocapital have co-led a €4.75m series-B funding round for Trod Medical, a Belgian medical devices company.
F-star raises €9.4m from Atlas, Aescap et al.
Biopharmaceutical company F-star has raised €9.4m in a series-A round supported by Altas Venture, Aescap Venture, TVM Capital among others.
HTGF backs dentaZoom in seed round
High-Tech Gründerfonds (HTGF) has backed dental microscopes manufacturer dentaZoom in a seed round thought to be worth €500,000.
Mid Europa’s Diagnostyka buys Olympus Consilio
Mid Europa Partners-backed Diagnostyka has acquired Poland-based Olympus Consilio as part of the GP’s consolidation strategy of the laboratory market in the CEE region.
Almi invests in Xintela
Almi Invest has backed Lund-based Xintela, a Swedish biomedical company, as part of a SEK 6m funding round.
Mid Europa's Alpha Medical buys Euromedic’s laboratories
Alpha Medical, a provider of laboratory testing services backed by Mid Europa Partners, has acquired the Czech laboratory business of medical services provider Euromedic.
BC Partners' Aenova acquires Haupt Pharma Gruppe
Aenova, a BC Partners-backed manufacturer of medicines and dietary supplements, has bought a majority stake in pharmaceutical company Haupt Pharma Gruppe.
R Capital’s LDR Medical floats on Nasdaq
R Capital Management portfolio company LDR Medical raised $75m in an IPO on the Nasdaq, giving the company a market cap of $489m.
Gimv fully exits Ablynx
Gimv has sold its remaining direct stake of 2.24% in Euronext-listed Ablynx, a Belgian biotechnology company, for €19.1m.